CorrectSequence Therapeutics
About:
CorrectSequence Therapeutics is a clinical-stage biotech company for next-generation gene editing therapies.
Website: http://www.correctsequence.com/?lang=en
Top Investors: HongShan, TF Capital, Zoo Capital, New Alliance Capital
Description:
Total Funding Amount:
40M CNY
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2020-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2021-01-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai